|
Budget Impact Analysis on the intranasal form of Interferon-Gamma in the Complex Therapy of Influenza in the Russian Federation
|
|
| Author:
|
S.L. PLAVINSKIY, P.I. SHABALKIN, J.A. ISAKOVA
|
| Abstract:
|
To estimate the budget impact on the intranasal form of interferon-gamma for the health care system of the Russian
Federation, data was used from the research work by Sologub T.V. et al. on the evaluation of clinical and economic
efficiency and the profitability of using recombinant interferon-gamma (Ingaron) in complex therapy of influenza
patients. The conducted calculations using the cost-effectiveness indicator for recombinant interferon-gamma showed
a positive budget impact for the health care system: in the form of a total budget savings of 1331568 thousand rubles
with the subsequent reduction of the estimated indicator of the economic burden of influenza on 43% that will be
reflected in the budget savings of 1018909 thousand rubles with current incidence.
|
| Keyword:
|
influenza, interferon-gamma, budget impact analysis, acute infections of the upper respiratory tract
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2018.10.04.053
|
| Download:
|
Request For Article
|
|
|